Stock Comparison
AZN vs JNJ
AstraZeneca PLC and Johnson & Johnson side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$242.97B
$626.01B
P/E (TTM)
23.5
30.1
Forward P/E
15.3
22.3
Price/Sales
4.0
6.4
Price/Book
4.8
7.4
EV/EBITDA
13.2
19.3
Dividend Yield
2.73%
2.00%
Profitability
Net Margin
17.19%
21.83%
Operating Margin
23.69%
26.87%
Return on Equity
22.00%
25.70%
Return on Assets
8.02%
8.60%
Growth (YoY)
Revenue Growth
6.40%
6.60%
Earnings Growth
2.50%
-0.90%
Price & Risk
Beta
0.2
0.2
52-Week High
$208.45
$267.34
52-Week Low
$144.05
$170.46
Analyst Target
$213.69
$272.50
Compare AZN and JNJ your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.